These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23123053)

  • 21. [Evidence on the key role of the metabotrobic glutamatergic receptors in the pathogenesis of schizophrenia: a "breakthrough" in pharmacological treatment].
    Pannese R; Minichino A; Pignatelli M; Delle Chiaie R; Biondi M; Nicoletti F
    Riv Psichiatr; 2012; 47(2):149-69. PubMed ID: 22622251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of spinal metabotropic glutamate receptors elicits cardiovascular responses in pentobarbital anesthetized rats.
    Celuch SM; García Mdel C
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):343-9. PubMed ID: 12237748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro characterisation of the novel positive allosteric modulators of the mGlu₅ receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat.
    Gilmour G; Broad LM; Wafford KA; Britton T; Colvin EM; Fivush A; Gastambide F; Getman B; Heinz BA; McCarthy AP; Prieto L; Shanks E; Smith JW; Taboada L; Edgar DM; Tricklebank MD
    Neuropharmacology; 2013 Jan; 64():224-39. PubMed ID: 22884720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.
    Mercier MS; Lodge D
    Neurochem Res; 2014 Oct; 39(10):1876-94. PubMed ID: 25146900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration.
    Tatarczyńska E; Kłodzińska A; Kroczka B; Chojnacka-Wójcik E; Pilc A
    Psychopharmacology (Berl); 2001 Oct; 158(1):94-9. PubMed ID: 11685389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel role for the metabotropic glutamate receptor-7: modulation of faecal water content and colonic electrolyte transport in the mouse.
    Julio-Pieper M; Hyland NP; Bravo JA; Dinan TG; Cryan JF
    Br J Pharmacol; 2010 May; 160(2):367-75. PubMed ID: 20423346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord.
    Howson PA; Jane DE
    Br J Pharmacol; 2003 May; 139(1):147-55. PubMed ID: 12746233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chronic gestational treatment with the adenosine A1 receptor agonist R-phenylisopropyladenosine on metabotropic glutamate receptors/phospholipase C pathway in maternal and fetal brain.
    León DA; Albasanz JL; Castillo CA; Iglesias I; Martín M
    J Neurosci Res; 2008 Nov; 86(15):3295-305. PubMed ID: 18615645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4.
    Volpi C; Fallarino F; Mondanelli G; Macchiarulo A; Grohmann U
    Expert Opin Drug Discov; 2018 May; 13(5):411-423. PubMed ID: 29486616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G protein-coupled receptor signalling in astrocytes in health and disease: a focus on metabotropic glutamate receptors.
    Bradley SJ; Challiss RA
    Biochem Pharmacol; 2012 Aug; 84(3):249-59. PubMed ID: 22531220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabotropic glutamate receptor trafficking.
    Suh YH; Chang K; Roche KW
    Mol Cell Neurosci; 2018 Sep; 91():10-24. PubMed ID: 29604330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of hippocampal metabotropic glutamate receptor 7 (mGlu7) mRNA levels in two animal models of depression.
    O'Mahony CM; Bravo JA; Dinan TG; Cryan JF
    Neurosci Lett; 2010 Sep; 482(2):137-41. PubMed ID: 20638442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabotropic Glutamate Receptors in Central Nervous System Diseases.
    Golubeva AV; Moloney RD; O'Connor RM; Dinan TG; Cryan JF
    Curr Drug Targets; 2016; 17(5):538-616. PubMed ID: 25777273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabotropic glutamate receptors as drug targets: what's new?
    Nicoletti F; Bruno V; Ngomba RT; Gradini R; Battaglia G
    Curr Opin Pharmacol; 2015 Feb; 20():89-94. PubMed ID: 25506748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurobiological insights and novel therapeutic opportunities for CNS disorders from mGlu receptor allosteric and biased modulation.
    Hellyer S; Leach K; Gregory KJ
    Curr Opin Pharmacol; 2017 Feb; 32():49-55. PubMed ID: 27842256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.
    Yin S; Niswender CM
    Cell Signal; 2014 Oct; 26(10):2284-97. PubMed ID: 24793301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological roles and therapeutic potential of metabotropic glutamate receptors.
    Conn PJ
    Ann N Y Acad Sci; 2003 Nov; 1003():12-21. PubMed ID: 14684432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabotropic glutamate receptors as drug targets for the treatment of absence epilepsy.
    Ngomba RT; van Luijtelaar G
    Curr Opin Pharmacol; 2018 Feb; 38():43-50. PubMed ID: 29547778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging signalling and protein interactions mediated via metabotropic glutamate receptors.
    Moldrich RX; Beart PM
    Curr Drug Targets CNS Neurol Disord; 2003 Apr; 2(2):109-22. PubMed ID: 12769803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.